ROFLUMILAST COMPOSITIONS FOR THE TREATMENT OF COPD

摘要

The present invention relates to pharmaceutical compositions comprising roflumilast in combination with a corticosteroid and/or a leukotriene receptor antagonist. The invention also relates to the use of such compositions for the treatment of Chronic Obstructive Pulmonary Disorder (COPD).

主权项

1. A pharmaceutical composition comprising roflumilast or a pharmaceutically acceptable salt, ester, prodrug, or pharmaceutically acceptable salts of esters or prodrugs, or N-oxide thereof in combination with a corticosteroid or a pharmaceutically acceptable salt, ester, prodrug, or pharmaceutically acceptable salt of ester or prodrug thereof and a pharmaceutically acceptable excipient.